Vor Biopharma
Tracked across 2 events · 18 articles · First seen Apr 01, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Vor Biopharma's stock experienced significant sales by a major institutional investor, leading to a decrease in its stock price and market capitalization. Despite this, analysts maintain a 'Moderate Buy' consensus.
Apr 11, 2026 · 6 articles
Business
Impact: Vor Biopharma granted stock options and restricted stock units to newly hired employees as an inducement to employment, which is a positive move for employee retention and growth.
Apr 01, 2026 · 12 articles
90
Vor Biopharma granted stock optionsVor Bio Grants Employee Stock
ERGEN INTELLIGENCE
Track Vor Biopharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard